Literature DB >> 10769035

Activated Ras prevents downregulation of Bcl-X(L) triggered by detachment from the extracellular matrix. A mechanism of Ras-induced resistance to anoikis in intestinal epithelial cells.

K Rosen1, J Rak, T Leung, N M Dean, R S Kerbel, J Filmus.   

Abstract

Detachment of epithelial cells from the extracellular matrix (ECM) results in a form of apoptosis often referred to as anoikis. Transformation of intestinal epithelial cells by oncogenic ras leads to resistance to anoikis, and this resistance is required for the full manifestation of the malignant phenotype. Previously, we demonstrated that ras-induced inhibition of anoikis in intestinal epithelial cells results, in part, from the ras-induced constitutive downregulation of Bak, a pro-apoptotic member of the Bcl-2 family. Since exogenous Bak could only partially restore susceptibility to anoikis in the ras-transformed cells, the existence of at least another component of the apoptotic machinery mediating the effect of activated ras on anoikis was suggested. Indeed, here we show that, in nonmalignant rat and human intestinal epithelial cells, detachment from the ECM or disruption of the cytoskeleton results in a significant downregulation of the antiapoptotic effector Bcl-X(L), and that activated H- or K-ras oncogenes completely abrogate this downregulation. In addition, we found that enforced downregulation of Bcl-X(L) in the ras-transformed cells promotes anoikis and significantly inhibits tumorigenicity, indicating that disruption of the adhesion-dependent regulation of Bcl-X(L) is an essential part of the molecular changes associated with transformation by ras. While the ras-induced downregulation of Bak could be reversed by pharmacological inhibition of phosphatidylinositol 3 kinase (PI 3-kinase), the effect of ras on Bcl-X(L) was PI 3-kinase- and mitogen-activated protein kinase (MAP kinase)-independent. We conclude that ras-induced resistance to anoikis in intestinal epithelial cells is mediated by at least two distinct mechanisms: one that triggers downregulation of Bak and another that stabilizes Bcl-X(L) expression in the absence of the ECM.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10769035      PMCID: PMC2175156          DOI: 10.1083/jcb.149.2.447

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  44 in total

Review 1.  Ras effectors.

Authors:  C J Marshall
Journal:  Curr Opin Cell Biol       Date:  1996-04       Impact factor: 8.382

Review 2.  PI3K: downstream AKTion blocks apoptosis.

Authors:  T F Franke; D R Kaplan; L C Cantley
Journal:  Cell       Date:  1997-02-21       Impact factor: 41.582

Review 3.  Signal transduction from multiple Ras effectors.

Authors:  M E Katz; F McCormick
Journal:  Curr Opin Genet Dev       Date:  1997-02       Impact factor: 5.578

4.  Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras.

Authors:  P Rodriguez-Viciana; P H Warne; A Khwaja; B M Marte; D Pappin; P Das; M D Waterfield; A Ridley; J Downward
Journal:  Cell       Date:  1997-05-02       Impact factor: 41.582

5.  Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway.

Authors:  A Khwaja; P Rodriguez-Viciana; S Wennström; P H Warne; J Downward
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

6.  Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.

Authors:  M Krajewska; S F Moss; S Krajewski; K Song; P R Holt; J C Reed
Journal:  Cancer Res       Date:  1996-05-15       Impact factor: 12.701

7.  Phosphatidylinositol-3-OH kinase as a direct target of Ras.

Authors:  P Rodriguez-Viciana; P H Warne; R Dhand; B Vanhaesebroeck; I Gout; M J Fry; M D Waterfield; J Downward
Journal:  Nature       Date:  1994-08-18       Impact factor: 49.962

8.  The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal.

Authors:  S G Kennedy; A J Wagner; S D Conzen; J Jordán; A Bellacosa; P N Tsichlis; N Hay
Journal:  Genes Dev       Date:  1997-03-15       Impact factor: 11.361

9.  Induction of cyclin D1 overexpression by activated ras.

Authors:  J Filmus; A I Robles; W Shi; M J Wong; L L Colombo; C J Conti
Journal:  Oncogene       Date:  1994-12       Impact factor: 9.867

10.  Massive programmed cell death in intestinal epithelial cells induced by three-dimensional growth conditions: suppression by mutant c-H-ras oncogene expression.

Authors:  J Rak; Y Mitsuhashi; V Erdos; S N Huang; J Filmus; R S Kerbel
Journal:  J Cell Biol       Date:  1995-12       Impact factor: 10.539

View more
  45 in total

1.  Matrix-independent survival of human keratinocytes through an EGF receptor/MAPK-kinase-dependent pathway.

Authors:  M Jost; T M Huggett; C Kari; U Rodeck
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

2.  Overexpression of LIM kinase 1 renders resistance to apoptosis in PC12 cells by inhibition of caspase activation.

Authors:  E Yang; H Kim; J Lee; J S Shin; H Yoon; S J Kim; I H Choi
Journal:  Cell Mol Neurobiol       Date:  2004-04       Impact factor: 5.046

3.  Acquisition of anoikis resistance through CD147 upregulation: A new mechanism underlying metastasis of hepatocellular carcinoma cells.

Authors:  Xia Ke; Ling Li; Hong-Lin Dong; Zhi-Nan Chen
Journal:  Oncol Lett       Date:  2012-03-27       Impact factor: 2.967

4.  Tumor levels of the mediators of ErbB2-driven anoikis resistance correlate with breast cancer relapse in patients receiving trastuzumab-based therapies.

Authors:  Alexi Surette; Byong Hoon Yoo; Tallal Younis; Kara Matheson; Tarek Rameh; Jaime Snowdon; Gillian Bethune; Kirill V Rosen
Journal:  Breast Cancer Res Treat       Date:  2021-03-16       Impact factor: 4.872

5.  Identification of target actin content and polymerization status as a mechanism of tumor resistance after cytolytic T lymphocyte pressure.

Authors:  Soraya Abouzahr; Georges Bismuth; Catherine Gaudin; Oliver Caroll; Peter Van Endert; Abdelali Jalil; Jean Dausset; Isabelle Vergnon; Catherine Richon; Audrey Kauffmann; Jérôme Galon; Graca Raposo; Fathia Mami-Chouaib; Salem Chouaib
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

6.  Anoikis, initiated by Mcl-1 degradation and Bim induction, is deregulated during oncogenesis.

Authors:  Nicholas T Woods; Hirohito Yamaguchi; Francis Y Lee; Kapil N Bhalla; Hong-Gang Wang
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

7.  Miniaturization of an Anoikis assay using non-adhesive micromolded hydrogels.

Authors:  Adam P Rago; Anthony P Napolitano; Dylan M Dean; Peter R Chai; Jeffrey R Morgan
Journal:  Cytotechnology       Date:  2007-12-22       Impact factor: 2.058

Review 8.  Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression.

Authors:  Cassandra L Buchheit; Kelsey J Weigel; Zachary T Schafer
Journal:  Nat Rev Cancer       Date:  2014-08-07       Impact factor: 60.716

9.  Acquisition of anoikis resistance promotes the emergence of oncogenic K-ras mutations in colorectal cancer cells and stimulates their tumorigenicity in vivo.

Authors:  Mathieu Derouet; Xue Wu; Linda May; Byong Hoon Yoo; Takehiko Sasazuki; Senji Shirasawa; Janusz Rak; Kirill V Rosen
Journal:  Neoplasia       Date:  2007-07       Impact factor: 5.715

10.  Oncogenic ras-induced down-regulation of autophagy mediator Beclin-1 is required for malignant transformation of intestinal epithelial cells.

Authors:  Byong Hoon Yoo; Xue Wu; Yongling Li; Mehnaaz Haniff; Takehiko Sasazuki; Senji Shirasawa; Eeva-Liisa Eskelinen; Kirill V Rosen
Journal:  J Biol Chem       Date:  2009-09-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.